remede System
Device
ZOLL Respicardia, Inc.
Total Payments
$4.9M
Transactions
4,803
Doctors
2,193
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $718,345 | 1,675 | 902 |
| 2023 | $632,100 | 1,682 | 927 |
| 2022 | $565,248 | 325 | 211 |
| 2021 | $535,891 | 425 | 363 |
| 2020 | $554,502 | 155 | 95 |
| 2019 | $589,803 | 324 | 199 |
| 2018 | $306,558 | 128 | 80 |
| 2017 | $974,371 | 89 | 26 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.4M | 441 | 48.5% |
| Consulting Fee | $1.2M | 145 | 25.4% |
| Travel and Lodging | $331,614 | 480 | 6.8% |
| Food and Beverage | $319,526 | 3,637 | 6.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $236,977 | 51 | 4.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $179,586 | 20 | 3.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $174,200 | 27 | 3.6% |
| Acquisitions | $32,014 | 1 | 0.7% |
| Entertainment | $2,500 | 1 | 0.1% |
Payments by Type
General
$2.5M
4,362 transactions
Research
$2.4M
441 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ZOLL Respicardia, Inc. Registry Study | ZOLL Respicardia, Inc. | $831,277 | 0 |
| Respicardia, Inc. Pivotal Trial of the remede System | Respicardia, Inc. | $713,582 | 0 |
| Respicardia, Inc. Post Approval Study of the remede System | Respicardia, Inc. | $326,554 | 0 |
| Respicardia, Inc. Registry Study of the remede System | Respicardia, Inc. | $203,967 | 0 |
| Respicardia, Inc. Registry Study of the remede System | ZOLL Respicardia, Inc. | $166,741 | 0 |
| ZOLL Respicardia, Inc. Janus Study | ZOLL Respicardia, Inc. | $31,904 | 0 |
| Respicardia, Inc. Post Approval Study of the remede System | ZOLL Respicardia, Inc. | $31,715 | 0 |
| Respicardia, Inc. Janus Study Feasibility Study | Respicardia, Inc. | $29,219 | 0 |
| Respicardia, Inc. Janus Study Feasibility Study | ZOLL Respicardia, Inc. | $17,370 | 0 |
| Chronic Evaluation of Respicardia Therapy | Respicardia, Inc. | $8,627 | 0 |
| ZOLL Respicardia, Inc. Cognitive Study | ZOLL Respicardia, Inc. | $2,591 | 0 |
Top Doctors Receiving Payments for remede System — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Rochester, MN | $13,026 | 6 |
| , M.D | Specialist | Los Angeles, CA | $12,983 | 3 |
| , M.D | Otolaryngology | Burr Ridge, IL | $11,684 | 9 |
| , M.D | Internal Medicine | Jacksonville, FL | $11,130 | 4 |
| , MD | Anesthesiology | Miami, FL | $10,631 | 3 |
| , MBBS | Neurology | Houston, TX | $10,269 | 7 |
| , MD | Clinical Cardiac Electrophysiology | Minneapolis, MN | $9,589 | 4 |
| , M.D | Clinical Cardiac Electrophysiology | Greenville, SC | $9,146 | 10 |
| , M.D | Internal Medicine | San Francisco, CA | $8,687 | 3 |
| , NP | Adult Health | Grapevine, TX | $8,518 | 8 |
| , MD | Neurology | Sacramento, CA | $8,356 | 3 |
| , MSN, FNP-BC | Family | Davenport, IA | $7,708 | 6 |
| , MD | Cardiovascular Disease | Boston, MA | $7,679 | 3 |
| , M.D | Internal Medicine | Morgantown, WV | $7,273 | 6 |
| , MD | Cardiovascular Disease | New York, NY | $6,945 | 8 |
| , MD | Critical Care Medicine | Columbus, OH | $6,895 | 10 |
| , MD | Emergency Medical Services | Dallas, TX | $6,747 | 3 |
| , MD, MS | Internal Medicine | San Francisco, CA | $6,165 | 5 |
| , M.D | Pulmonary Disease | Tucson, AZ | $5,762 | 5 |
| , MD | Clinical Cardiac Electrophysiology | Denver, CO | $5,740 | 8 |
| , MD | Cardiovascular Disease | Kansas City, MO | $5,673 | 5 |
| , M.D | Internal Medicine | Lake Worth, FL | $5,584 | 5 |
| , M.D | Internal Medicine | Houston, TX | $5,425 | 4 |
| , MD | Pulmonary Disease | Cleveland, OH | $5,394 | 5 |
| , MD | Critical Care Medicine | Washington, DC | $5,128 | 2 |
Ad
Manufacturing Companies
- ZOLL Respicardia, Inc. $2.5M
- Respicardia, Inc. $2.4M
Product Information
- Type Device
- Total Payments $4.9M
- Total Doctors 2,193
- Transactions 4,803
About remede System
remede System is a device associated with $4.9M in payments to 2,193 healthcare providers, recorded across 4,803 transactions in the CMS Open Payments database. The primary manufacturer is ZOLL Respicardia, Inc..
Payment data is available from 2017 to 2024. In 2024, $718,345 was paid across 1,675 transactions to 902 doctors.
The most common payment nature for remede System is "Unspecified" ($2.4M, 48.5% of total).
remede System is associated with 11 research studies, including "ZOLL Respicardia, Inc. Registry Study" ($831,277).